Now that Momenta has provided info regarding the immediate sale and pricing of Copax todays stock action is somewhat disappointing.
On top of that they have announce a new profit calculation regarding enox.
I wonder if it's the slight discount that has spooked investors. 15% doesn't seem that people will flock to the generic unless some deals are worked out with the insurers.
Market Data 
Markets 
AI
